|
| 36162136 | Treatment Strategies and Mechanisms Associated with the Prevention of NASH-Associated HCC by a Toll-like Receptor 4 Inhibitor. | Cancer Prev Res (Phila) | 2023 |
| 37583424 | Targeting nuclear hormone receptors for the prevention of breast cancer. | Front Med (Lausanne) | 2023 |
| 37259799 | Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ. | Cancer Prev Res (Phila) | 2023 |
| 36951827 | Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive Breast Cancer: A Randomized Clinical Trial. | JAMA Oncol | 2023 |
| 37207208 | Naproxen chemoprevention induces proliferation of cytotoxic lymphocytes in Lynch Syndrome colorectal mucosa. | Front Immunol | 2023 |
| 36720042 | CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer. | Cancer Res | 2023 |
| 36228112 | Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer. | Cancer Prev Res (Phila) | 2023 |
| 35981902 | Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer. | Cancer Prev Res (Phila) | 2022 |
| 35697807 | Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression. | Nat Biotechnol | 2022 |
| 36001346 | Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy. | Cancer Prev Res (Phila) | 2022 |
| 32641470 | Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa. | Gut | 2021 |
| 33842408 | Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting. | J Cancer Prev | 2021 |
| 33556158 | Response to Braillon. | JNCI Cancer Spectr | 2021 |
| 34216815 | Alternative dosing of exemestane in postmenopausal women with ER-positive breast cancer. Design and methods of a randomized presurgical trial. | Contemp Clin Trials | 2021 |
| 33277315 | Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP). | Cancer Prev Res (Phila) | 2021 |
| 32661114 | SOX9 Is Essential for Triple-Negative Breast Cancer Cell Survival and Metastasis. | Mol Cancer Res | 2020 |
| 31909186 | Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1. | NPJ Breast Cancer | 2020 |
| 31961339 | TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination. | J Clin Invest | 2020 |
| 33409459 | Low-Dose Aspirin in High-Risk Individuals With Screen-Detected Subsolid Lung Nodules: A Randomized Phase II Trial. | JNCI Cancer Spectr | 2020 |
| 31138522 | Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812). | Cancer Prev Res (Phila) | 2019 |
| 31372497 | The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progression. | NPJ Breast Cancer | 2019 |
| 31097774 | A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment. | Br J Cancer | 2019 |
| 29453232 | A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease. | Cancer Prev Res (Phila) | 2018 |
| 29618460 | A System-Level Approach to Improve the Uptake of Antiestrogen Preventive Therapy among Women with Atypical Hyperplasia and Lobular Cancer <i>In Situ</i>. | Cancer Prev Res (Phila) | 2018 |
| 29554350 | NSAIDs to Prevent Breast Cancer Recurrence? An Unanswered Question. | J Natl Cancer Inst | 2018 |
| 28819400 | Rapid Breast Cancer Disease Progression Following Cyclin Dependent Kinase 4 and 6 Inhibitor Discontinuation. | J Cancer | 2017 |
| 28087641 | Molecular Pathways: Targeting Protein Tyrosine Phosphatases in Cancer. | Clin Cancer Res | 2017 |
| 28297605 | Identifying Cell Cycle Modulators That Selectively Target ARID1A Deficiency Using High-Throughput Image-Based Screening. | SLAS Discov | 2017 |
| 28373182 | Energy Balance Modulation Impacts Epigenetic Reprogramming, ERα and ERβ Expression, and Mammary Tumor Development in MMTV-neu Transgenic Mice. | Cancer Res | 2017 |
| 28143870 | Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials. | Clin Cancer Res | 2017 |
| 29112893 | Natural product β-thujaplicin inhibits homologous recombination repair and sensitizes cancer cells to radiation therapy. | DNA Repair (Amst) | 2017 |
| 28643165 | Molecularly targeted therapies for p53-mutant cancers. | Cell Mol Life Sci | 2017 |
| 26894864 | The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression. | Oncotarget | 2016 |
| 28721383 | Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630. | NPJ Breast Cancer | 2016 |
| 26675741 | Women's Expectations for Breast Cancer Prevention and Early Detection: High Expectations Can Be Achieved. | Oncologist | 2016 |
| 27393618 | Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion. | Breast Cancer Res Treat | 2016 |
| 27322462 | Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer. | EBioMedicine | 2016 |
| 27225691 | Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer. | Clin Cancer Res | 2016 |
| 27287781 | Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer. | Breast Cancer Res Treat | 2016 |
| 26965145 | Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance. | Mol Cancer Res | 2016 |
| 26921331 | Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival. | Cancer Res | 2016 |
| 26970124 | Retinoids and rexinoids in cancer prevention: from laboratory to clinic. | Semin Oncol | 2016 |
| 24646362 | Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer. | J Hum Nutr Diet | 2015 |
| 26471236 | Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus. | Cancer Prev Res (Phila) | 2015 |
| 26284997 | Molecular cancer prevention: Current status and future directions. | CA Cancer J Clin | 2015 |
| 26075823 | Death-associated protein kinase 1 promotes growth of p53-mutant cancers. | J Clin Invest | 2015 |
| 26069190 | ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors. | Cancer Discov | 2015 |
| 26063617 | TLR4 has a TP53-dependent dual role in regulating breast cancer cell growth. | Proc Natl Acad Sci U S A | 2015 |
| 25605252 | Functional consequence of the MET-T1010I polymorphism in breast cancer. | Oncotarget | 2015 |
| 25208879 | Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer. | Clin Cancer Res | 2015 |